Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 18 (2), 111-35

Idiopathic Short Stature: Management and Growth Hormone Treatment

Affiliations
Review

Idiopathic Short Stature: Management and Growth Hormone Treatment

J M Wit et al. Growth Horm IGF Res.

Abstract

In the management of ISS auxological, biochemical, psychosocial and ethical elements have to be considered. In boys with constitutional delay of growth and puberty androgens are effective in increasing height and sexual characteristics, but adult height is unchanged. GH therapy is efficacious in increasing height velocity and adult height, but the inter-individual variation is considerable. The effect on psychosocial status is uncertain. Factors affecting final height gain include GH dose, height deficit in comparison to midparental height, age and first year height velocity. In case of a low predicted adult height at the onset of puberty, addition of a GnRH analogue can be considered. Although GH therapy appears safe, long-term monitoring is recommended.

Similar articles

See all similar articles

Cited by 15 articles

See all "Cited by" articles

Substances

Feedback